THL

Bynder Announces Majority Investment from Thomas H. Lee Partners

Retrieved on: 
星期二, 十二月 20, 2022
Professional Services, Technology, Software, Finance, Asset Management, Fintech, Digital Cash Management, Digital Assets, Organization, Health care, Insight Partners, PIM, Puma, DAM, Fusion Global Business Solutions, Partnership, Growth, Marketing, Digital asset management, Icelandair, Thomas H. Lee Partners, Multimedia, THL, Collection, Spotify, Product information management, Commerce, Automation, Software as a service, Acquisition, William Blair & Company, Lincoln International, Video game, Bazaarvoice

Bynder (“the company”), a global leader in Digital Asset Management (DAM), today announced that it will receive a majority investment from Thomas H. Lee Partners, L.P. (“THL”), a premier private equity firm investing in growth companies.

Key Points: 
  • Bynder (“the company”), a global leader in Digital Asset Management (DAM), today announced that it will receive a majority investment from Thomas H. Lee Partners, L.P. (“THL”), a premier private equity firm investing in growth companies.
  • As part of the transaction, THL will acquire Insight Partners' stake in Bynder.
  • Arma Partners and Lincoln International acted as financial advisors to Bynder on this transaction.
  • Thomas H. Lee Partners, L.P. (“THL”) is a premier private equity firm investing in middle-market growth companies exclusively within three sectors: Healthcare, Financial Technology & Services, and Technology & Business Solutions.

8th Annual Women in Investing Summit at Harvard Business School Announces Speakers and Agenda

Retrieved on: 
星期二, 十一月 29, 2022
Professional Services, Education, Business, Consumer, Women, Finance, University, Metaverse, HBS, Harvard University, Advent International, Harvest Partners, Marketplace, Private equity, General Catalyst, Baupost Group, AEA, Bain Capital, CVC, Female, THL, Student, Silva International Investments, PE, Summit, PSG, Oak Hill Capital Partners, WII, Genstar, American Securities, TA Associates, VERITAS, Fellows, Senior, Berkshire Partners, International, VC, Francisco Partners, Providence Equity, Harvard Business School, General partnership, Woman, Harvard College, Court Square, EQT, Management, Fidelity, Health care, Growth, Centerbridge Partners

The Women in Investing Club (WII), a student club at Harvard Business School, will hold the 8th annual Women in Investing Summit on Saturday, December 3, 2022, at Klarman Hall, Harvard Business School.

Key Points: 
  • The Women in Investing Club (WII), a student club at Harvard Business School, will hold the 8th annual Women in Investing Summit on Saturday, December 3, 2022, at Klarman Hall, Harvard Business School.
  • This years conference will feature several new and exciting panels, including Emergent Fund Strategies, International Investing, Web3 & Metaverse, Technology in Healthcare, and B2B SaaS.
  • We are excited to carry on the tradition of hosting top female investors from around the world at our 8th annual Summit, said Women in Investing Presidents, Jenny Park, Jessica Li, and Ana Keusch.
  • The Harvard name and the VERITAS shield are trademarks of the President and Fellows of Harvard College and are used by permission of Harvard University.

Thomas H. Lee Partners Appoints Paul Black As a Consultant for Healthcare Group

Retrieved on: 
星期二, 十月 11, 2022
Software, Finance, General Health, Health, Data Management, Health Technology, Professional Services, Technology, Intelligent Medical Objects, CERN, MDRX, Dwight D. Eisenhower Presidential Library, Museum and Boyhood Home, Growth, Technology, HealthEquity, NASDAQ, COO, Investment, Partnership, Community, Invenio Business Solutions, THL, Acquisition, Paul Black, Black, CEO, HQY, Cerner, University of Kansas Health System, Solution, Pharmaceutical industry, Management, Health care, Allscripts

Thomas H. Lee Partners, L.P. (THL), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Paul Black as a consultant for the firms healthcare investment group.

Key Points: 
  • Thomas H. Lee Partners, L.P. (THL), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Paul Black as a consultant for the firms healthcare investment group.
  • We are very pleased to welcome Paul to THL as a consultant for the firms healthcare group, said Shahab Vagefi, Managing Director at THL.
  • In this role, Black will support the healthcare group in deal sourcing, due diligence for potential investments, and developing new relationships with founders and management teams across the healthcare landscape.
  • THLs thesis-driven approach and dedicated focus on Healthcare IT has enabled it to work with unique companies across the healthcare landscape, said Paul Black.

TorHoerman Law Attorneys Awarded $4.4 million Verdict for Plaintiffs' Suffering Popcorn Lung from Diacetyl Exposure

Retrieved on: 
星期二, 九月 13, 2022
Respiratory tract, Epidemiology, Personal protective equipment, Partnership, Toxicology, Smell, Thromboangiitis obliterans, Workplace, THL, Degenerative disease, Taste, Radiation-induced lung injury, Multimedia, Hostile witness, PPE, Butter, Insurance, Tobacco, Health insurance, Diacetyl

Diacetyl is a chemical compound, both man-made and naturally occurring in some food manufacturing processes, that mimics the taste, texture and smell of butter.

Key Points: 
  • Diacetyl is a chemical compound, both man-made and naturally occurring in some food manufacturing processes, that mimics the taste, texture and smell of butter.
  • Though Diacetyl is safe for ingestion in its natural state, it is dangerous when heated into a vapor and inhaled, potentially causing Bronchiolitis Obliterans, also known as "Popcorn Lung".
  • The THL team represented three plaintiffs with respiratory injuries from exposure to dangerous levels of diacetyl in the workplace.
  • TorHoerman Law's efforts in fighting Diacetyl exposure cases is not over.

Biomea Fusion Presents Additional Preclinical Data Demonstrating Anti-Tumor Activity and Mechanistic Evidence for BMF-219 in Diffuse Large B-Cell Lymphoma and Multiple Myeloma Models at International Myeloma Society Annual Meeting

Retrieved on: 
星期五, 八月 26, 2022
MEIS1, IC50, CEO, Safety, Pharmacokinetics, Securities Act of 1933, Research, Gene, DLBCL, Toxicity, Multiple myeloma, Drug Quality and Security Act, TIP, OBD, DLT, U.S. Securities and Exchange Commission, GLOBE, ORR, DEL, Risk, DHL, HOXA9, TTP, Patient, Cardiovascular disease, Menin, Cancer, Protein, AML, Board, Collection, DNA, SEC, Acute leukemia, Securities Exchange Act of 1934, Mixed-phenotype acute leukemia, Progression-free survival, Nasdaq, Diabetes, MLL, PFS, Lists of diseases, Disease, Diffuse large B-cell lymphoma, AL, ECOG, DOR, Annual general meeting, IMS, Growth, B-cell lymphoma, MYC, IND, NRAS, KRAS, THL, Apoptosis, CNS, Vaccine, Pharmaceutical industry, Osteopathic medicine in Canada

We previously reported the ability of BMF-219 to modulate MYC expression and exhibit high potency against Double HIT Lymphoma (DHL) DLBCL (Diffuse Large B Cell Lymphoma) preclinical models.

Key Points: 
  • We previously reported the ability of BMF-219 to modulate MYC expression and exhibit high potency against Double HIT Lymphoma (DHL) DLBCL (Diffuse Large B Cell Lymphoma) preclinical models.
  • Additionally, we provide mechanistic evidence for direct inhibition of menin protein, in cell line models representing MM, DHL and DEL.
  • Collectively, our data demonstrate the novel and robust anti-tumor activity of BMF-219 in HGBCL and MM preclinical models that represent categories of high unmet need.
  • Biomea Fusion explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.

Carpe Data Appoints William Magowan as Chief Revenue Officer

Retrieved on: 
星期一, 八月 1, 2022
Insurance, Industry, CEO, VP, Allstate, Business architecture, Solution, Risk, VP/MS, Classification, THL, News, Policy, P&C, Centre for Study of Insurance Operations, Software as a service, Traveler, Efficiency, Growth, Automation, Management, Magowan, Farmer

SANTA BARBARA, Calif., Aug. 1, 2022 /PRNewswire/ -- Carpe Data, a next-generation provider of innovative emerging and alternative data products for the insurance industry, today announced the appointment of William Magowan as Chief Revenue Officer. He assumes the role from Jim Andrews, who has been named the Carpe Data's Chief Customer Officer, a new role created to advance the company's customer-centric philosophy amid a time of accelerated growth.

Key Points: 
  • SANTA BARBARA, Calif., Aug. 1, 2022 /PRNewswire/ -- Carpe Data , a next-generation provider of innovative emerging and alternative data products for the insurance industry, today announced the appointment of William Magowan as Chief Revenue Officer.
  • The news of Magowan's appointment comes in the middle of an active year for Carpe Data.
  • In addition, Carpe Data has continued to add blue chip customers, building on their continued momentum in the marketplace.
  • Carpe Data is the next-generation data company for insurance, transforming emerging data into predictive and actionable insights that enable automation and improve insurance outcomes across the policy lifecycle.

Finnish Biobanks (FINBB) Partners with TriNetX to Increase Clinical and Biomedical Trials in Finland

Retrieved on: 
星期二, 六月 14, 2022
GDPR, THL, Research, LLC, Biomedical Research, CEO, Partnership, Senior, EHR, Patient, Finnish Institute, Finnish Institute for Health and Welfare, Health, Twitter, University, HIPAA, Mobile phone, Pharmaceutical industry

The goal of the collaboration is to connect major Finnish healthcare organizations to FINBB's national collaborative known as the Fingenious service network, and to attract more research projects as well as increase the number of clinical trials in Finland.

Key Points: 
  • The goal of the collaboration is to connect major Finnish healthcare organizations to FINBB's national collaborative known as the Fingenious service network, and to attract more research projects as well as increase the number of clinical trials in Finland.
  • "We believe that the collaboration with the TriNetX network will help us reverse this trend in Finland for the benefit of patients suffering different kinds of devastating diseases.
  • TriNetX is the largest and fastest growing collaborative research network, representing healthcare organizations and health data partners across the world.
  • "We are excited to welcome FINBB to the TriNetX network," said Steve Lethbridge, Senior Vice President, Global Healthcare Partnerships at TriNetX.

Thomas H. Lee Partners Appoints Sam Hendler As Head of Business Development, Healthcare

Retrieved on: 
星期二, 六月 7, 2022
Software, Biotechnology, Insurance, Finance, General Health, Health, Professional Services, Technology, Fusion Global Business Solutions, THL, McNeil Consumer Healthcare, LLC, Health information technology, Optical disc image, Diversified Pharmaceutical Services, Care, Business development, Health care, Mergers and acquisitions, Partnership, Investment, Growth, Technology, Acquisition, Hendler, Identified, Harris Williams & Co., Healthcare, Management

Thomas H. Lee Partners, L.P. (THL), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Sam Hendler as Managing Director and Head of Business Development for the firms healthcare investment group.

Key Points: 
  • Thomas H. Lee Partners, L.P. (THL), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Sam Hendler as Managing Director and Head of Business Development for the firms healthcare investment group.
  • The firm currently invests in five healthcare sectors: Healthcare IT, Pharmaceutical Services, Home-based Care, Consumer Healthcare, and Medtech Services.
  • Prior to joining Thomas H. Lee Partners, Hendler served as a managing director at Harris Williams, where he established and managed the firms global healthcare IT practice.
  • Thomas H. Lee Partners, L.P. (THL) is a premier private equity firm investing in middle-market growth companies exclusively within three sectors: Healthcare, Financial Technology & Services, and Technology & Business Solutions.

Inriver Announces Growth Investment from Thomas H. Lee Partners

Retrieved on: 
星期四, 五月 19, 2022
Software, Company, THL, Investment, PIM, Thomas H. Lee Partners, Fusion Global Business Solutions, Health care, Technology, Commerce, LLP, Partnership, B2C, Sidley Austin, Organization, SRG, Calendar, Automation, Software as a service, On-premises software, Acquisition, Sustainable society, Growth, CEO, Online shopping, Bank, Industrifonden

MALMÖ, Sweden and CHICAGO, May 19, 2022 /PRNewswire/ -- Inriver ("the Company"), a company that empowers organizations to deliver revenue-driving product information management (PIM) across every customer touchpoint, today announced that it will receive a majority investment from Thomas H. Lee Partners, L.P. (THL), a premier private equity firm investing in growth companies. Verdane, the European specialist growth equity investor and current inriver shareholder, will retain a significant stake in the Company. The transaction will include a significant primary capital investment to support inriver's product development roadmap and significantly expand its presence in North America and Europe, to meet the demands of a high-growth market.

Key Points: 
  • Verdane, the European specialist growth equity investor and current inriver shareholder, will retain a significant stake in the Company.
  • "This is a milestone for inriver, our customers, partners, and investors," said Thomas Zanzinger, CEO of inriver.
  • Thomas H. Lee Partners, L.P. ("THL") is a premier private equity firm investing in middle-market growth companies exclusively within three sectors: Healthcare, Financial Technology & Services, and Technology & Business Solutions.
  • Verdane is a specialist growth equity investment firm that partners with tech-enabled and sustainable European businesses to help them reach the next stage of international growth.

Inriver Announces Growth Investment from Thomas H. Lee Partners

Retrieved on: 
星期四, 五月 19, 2022
Software, Company, THL, Investment, PIM, Thomas H. Lee Partners, Fusion Global Business Solutions, Health care, Technology, Commerce, LLP, Partnership, B2C, Sidley Austin, Organization, SRG, Calendar, Automation, Software as a service, On-premises software, Acquisition, Sustainable society, Growth, CEO, Online shopping, Bank, Industrifonden

MALMÖ, Sweden and CHICAGO, May 19, 2022 /PRNewswire/ -- Inriver ("the Company"), a company that empowers organizations to deliver revenue-driving product information management (PIM) across every customer touchpoint, today announced that it will receive a majority investment from Thomas H. Lee Partners, L.P. (THL), a premier private equity firm investing in growth companies. Verdane, the European specialist growth equity investor and current inriver shareholder, will retain a significant stake in the Company. The transaction will include a significant primary capital investment to support inriver's product development roadmap and significantly expand its presence in North America and Europe, to meet the demands of a high-growth market.

Key Points: 
  • Verdane, the European specialist growth equity investor and current inriver shareholder, will retain a significant stake in the Company.
  • "This is a milestone for inriver, our customers, partners, and investors," said Thomas Zanzinger, CEO of inriver.
  • Thomas H. Lee Partners, L.P. ("THL") is a premier private equity firm investing in middle-market growth companies exclusively within three sectors: Healthcare, Financial Technology & Services, and Technology & Business Solutions.
  • Verdane is a specialist growth equity investment firm that partners with tech-enabled and sustainable European businesses to help them reach the next stage of international growth.